Loading organizations...
Key people at patientgenie.
PatientGenie delivers an AI Agent Platform designed to streamline healthcare access for health plans and members. Its intelligent AI agent automates essential tasks, including scheduling, provider matching, and proactive care gap outreach. The platform supports omnichannel engagement via voice and text, integrating workflow automation and data intelligence within a secure, compliant framework to reduce administrative burdens.
Established in 2021, PatientGenie was co-founded by Alex Zoller, Brian Russon, and Steve Cashman. Zoller currently serves as CEO, Russon as Board Member, and Cashman as Executive Chair. Their foundational insight addressed the complexities of healthcare navigation, leading to the development of a patented private search engine for precise provider matching, simplifying how individuals connect with appropriate care.
The company primarily assists health plans, enabling significant improvements in member experience and operational efficiency. PatientGenie’s vision is to ensure timely and appropriate care through a unified, member-centric AI solution. This technology seeks to seamlessly connect plans, providers, and members, fostering a future where healthcare access is consistently frictionless and equitable for all.
Key people at patientgenie.
PatientGenie is an AI-powered healthcare navigation platform that simplifies access to care by connecting patients with in-network providers, automating appointment scheduling, and closing care gaps for health plans, systems, and providers.[1][2][3] It serves health plans primarily, offering member-centric tools like personalized care matching, conversational scheduling via voice/text, and real-time insights to reduce call center dependency and boost compliance with plan rules.[3][4] The platform solves fragmented healthcare navigation—addressing issues like provider discovery, insurance checks, and equitable access—through GenAI, patented algorithms, and integrations with triage, telehealth, and directories, with recent momentum from the full release of PatientGenie AI v1.0 backed by four U.S. patents.[1][2]
Founded in 2021 in Austin, Texas, PatientGenie emerged to tackle healthcare access barriers, with a mission to bridge people, plans, and providers through AI coordination for faster, more equitable care.[2][4] Key founders include Brian Russon, CEO with extensive hospital and healthcare executive experience, and Alex Zoller, a product leader with 20 years in healthcare, technology, and finance projects.[2] Early development focused on an AI-driven search engine powered by LLMs and a patented data engine, gaining traction through beta testing and partnerships before launching AI v1.0, marking a pivot to full-scale GenAI capabilities.[1][2]
PatientGenie rides the AI agent wave in healthcare, capitalizing on GenAI for automation amid rising demands for personalized, compliant care navigation in a fragmented $4+ trillion U.S. system.[1][3] Timing aligns with regulatory pushes for price transparency, telehealth expansion, and value-based care, where health plans face pressure to cut costs and close gaps—PatientGenie's tools directly enable this by automating 80-90% of routine interactions.[3] Market forces like LLM advancements and data interoperability favor its patented engine, positioning it to influence ecosystems through vendor collaborations and as a "digital master front door" for plans.[2]
PatientGenie is poised for rapid scaling as health plans prioritize AI to slash administrative burdens and elevate member satisfaction, with AI v1.0 signaling enterprise-ready maturity.[1][3] Upcoming trends like multimodal AI (voice/video) and deeper payer-provider integrations will amplify its edge, potentially expanding to direct-to-consumer or global markets while evolving influence through more patents and partnerships. This positions PatientGenie to redefine equitable access, turning navigation complexity into a competitive moat for its clients—echoing its founding promise that timely care shouldn't be hard to reach.[4]
